JP Morgan Chase’s Coya Therapeutics COYA Stock Holding History
Bought
Maintained
Sold
Other funds holding COYA
ACM
CM
JP Morgan Chase's COYA Position: Q3 2026 in Review
JP Morgan Chase reduced its Coya Therapeutics (COYA) stake by 3.4% in Q3 2026, selling an estimated $844 and leaving 5,004 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6838.
JP Morgan Chase first reported a position in COYA in Q3 2023 and has held it in 11 quarters since. The position peaked at $31.4K in Q2 2026. 52 funds tracked by Wall St. Rank hold COYA as of Q3 2026.
- JP Morgan Chase held 5,004 shares of Coya Therapeutics worth $25.2K as of Q3 2026.
- JP Morgan Chase sold 177 Coya Therapeutics shares in Q3 2026, an estimated $844.
- Coya Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #6838 holding.
- JP Morgan Chase first reported a position in Coya Therapeutics in Q3 2023 and has held it in 11 quarters since.
- JP Morgan Chase's Coya Therapeutics position peaked at $31.4K in Q2 2026.
- 52 funds tracked by Wall St. Rank held Coya Therapeutics as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.